SIRT1 and metabolic dysfunction-associated steatotic liver disease: In this respect, the property whereby macroH2A1.1 binds with very tight affinity with OAADPR produced by SIRT1 is intriguing, considering that the activation of these enzymes is considered protective against NAFLD favouring a overall healthy aging [38], and is under scrutiny for drug design [39, 40].